The mitochondrial fusion-associated protein MFN2 can be used as a novel prognostic molecule for clear cell renal cell carcinoma
Abstract Background Mitofusin 2 (MFN2) plays an important role in many tumors, but how its role in renal clear cell carcinoma needs further research. Methods In this study, we analyzed the expression of MFN2 in renal clear cell carcinoma tissues and normal kidney tissues through the Cancer Genome At...
Main Authors: | Bin Zhang, Dali Han, LiMing Yang, Yang He, Shujun Yang, Hongbo Wang, Xingxing Zhang, Yuelin Du, Wei Xiong, Hualan Ha, Panfeng Shang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-11419-8 |
Similar Items
-
MFN1 and MFN2 Are Dispensable for Sperm Development and Functions in Mice
by: Junru Miao, et al.
Published: (2021-12-01) -
Mfn2 inhibits proliferation and cell-cycle in Hela cells via Ras-NF-κB signal pathway
by: Xiaowen Liu, et al.
Published: (2019-07-01) -
High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma
by: Yuting Tang, et al.
Published: (2022-12-01) -
MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria‐dependent dephosphorylation of EGFR
by: Li Luo, et al.
Published: (2023-07-01) -
Prognostic value of sirtuin family members and experimental verification identify SIRT5 as diagnostic biomarkers in clear cell renal cell carcinoma
by: Lu-Shan Peng, et al.
Published: (2023-04-01)